Dipak-001/mistril_dataset huggingface dataset:
user: Who is at risk for Nasopharyngeal Cancer? ?

assistant: Ethnic background and being exposed to the Epstein-Barr virus can affect the risk of nasopharyngeal cancer. Anything that increases your risk of getting a disease is called a risk factor. Having a risk factor does not mean that you will get cancer; not having risk factors doesn't mean that you will not get cancer. Talk with your doctor if you think you may be at risk. Risk factors for nasopharyngeal cancer include the following:         - Having Chinese or Asian ancestry.    - Being exposed to the Epstein-Barr virus: The Epstein-Barr virus has been associated with certain cancers, including nasopharyngeal cancer and some lymphomas.    - Drinking large amounts of alcohol.
user: What are the symptoms of Nasopharyngeal Cancer ?

assistant: Signs of nasopharyngeal cancer include trouble breathing, speaking, or hearing. These and other signs and symptoms may be caused by nasopharyngeal cancer or by other conditions. Check with your doctor if you have any of the following:         - A lump in the nose or neck.    - A sore throat.    - Trouble breathing or speaking.    - Nosebleeds.    - Trouble hearing.    - Pain or ringing in the ear.    - Headaches.
user: What is the outlook for Nasopharyngeal Cancer ?

assistant: Certain factors affect prognosis (chance of recovery) and treatment options. The prognosis (chance of recovery) and treatment options depend on the following:         - The stage of the cancer (whether it affects part of the nasopharynx, involves the whole nasopharynx, or has spread to other places in the body).     - The type of nasopharyngeal cancer.     - The size of the tumor.    - The patients age and general health.
user: what research (or clinical trials) is being done for Nasopharyngeal Cancer ?

assistant: New types of treatment are being tested in clinical trials.
                    Information about clinical trials is available from the NCI website.
                
                
                    Patients may want to think about taking part in a clinical trial.
                    For some patients, taking part in a clinical trial may be the best treatment choice. Clinical trials are part of the cancer research process. Clinical trials are done to find out if new cancer treatments are safe and effective or better than the standard treatment.   Many of today's standard treatments for cancer are based on earlier clinical trials. Patients who take part in a clinical trial may receive the standard treatment or be among the first to receive a new treatment.   Patients who take part in clinical trials also help improve the way cancer will be treated in the future. Even when clinical trials do not lead to effective new treatments, they often answer important questions and help move research forward.
                
                
                    Patients can enter clinical trials before, during, or after starting their cancer treatment.
                    Some clinical trials only include patients who have not yet received treatment. Other trials test treatments for patients whose cancer has not gotten better. There are also clinical trials that test new ways to stop cancer from recurring (coming back) or reduce the side effects of cancer treatment.   Clinical trials are taking place in many parts of the country. See the Treatment Options section that follows for links to current treatment clinical trials. These have been retrieved from NCI's listing of clinical trials.
user: What is (are) Gastrointestinal Stromal Tumors ?

assistant: Key Points
                    - Gastrointestinal stromal tumor is a disease in which abnormal cells form in the tissues of the gastrointestinal tract.    - Genetic factors can increase the risk of having a gastrointestinal stromal tumor.     - Signs of gastrointestinal stromal tumors include blood in the stool or vomit.    - Tests that examine the GI tract are used to detect (find) and diagnose gastrointestinal stromal tumors.    - Very small GISTs are common.    - Certain factors affect prognosis (chance of recovery) and treatment options.
                
                
                    Gastrointestinal stromal tumor is a disease in which abnormal cells form in the tissues of the gastrointestinal tract.
                    The gastrointestinal (GI) tract is part of the bodys digestive system. It helps to digest food and takes nutrients (vitamins, minerals, carbohydrates, fats, proteins, and water) from food so they can be used by the body. The GI tract is made up of the following organs:         -  Stomach.    -  Small intestine.    -  Large intestine (colon).         Gastrointestinal stromal tumors (GISTs) may be malignant (cancer) or benign (not cancer). They are most common in the stomach and small intestine but may be found anywhere in or near the GI tract. Some scientists believe that GISTs begin in cells called interstitial cells of Cajal (ICC), in the wall of the GI tract.      See the PDQ summary about Unusual Cancers of Childhood Treatment for information on the treatment of GIST in children.
                
                 
                    Very small GISTs are common.
                    Sometimes GISTs are smaller than the eraser on top of a pencil. Tumors may be found during a procedure that is done for another reason, such as an x-ray or surgery. Some of these small tumors will not grow and cause signs or symptoms or spread to the abdomen or other parts of the body. Doctors do not agree on whether these small tumors should be removed or whether they should be watched to see if they begin to grow.
user: Who is at risk for Gastrointestinal Stromal Tumors? ?

assistant: Genetic factors can increase the risk of having a gastrointestinal stromal tumor. Anything that increases your risk of getting a disease is called a risk factor. Having a risk factor does not mean that you will get cancer; not having risk factors doesn't mean that you will not get cancer. Talk with your doctor if you think you may be at risk.   The genes in cells carry the hereditary information received from a persons parents. The risk of GIST is increased in people who have inherited a mutation (change) in a certain gene. In rare cases, GISTs can be found in several members of the same family.   GIST may be part of a genetic syndrome, but this is rare. A genetic syndrome is a set of symptoms or conditions that occur together and is usually caused by abnormal genes. The following genetic syndromes have been linked to GIST:         -  Neurofibromatosis type 1 (NF1).    -  Carney triad.
user: What are the symptoms of Gastrointestinal Stromal Tumors ?

assistant: Signs of gastrointestinal stromal tumors include blood in the stool or vomit. These and other signs and symptoms may be caused by a GIST or by other conditions. Check with your doctor if you have any of the following:         -  Blood (either bright red or very dark) in the stool or vomit.    - Pain in the abdomen, which may be severe.    - Feeling very tired.    - Trouble or pain when swallowing.    - Feeling full after only a little food is eaten.
user: what research (or clinical trials) is being done for Gastrointestinal Stromal Tumors ?

assistant: New types of treatment are being tested in clinical trials.
                    Information about clinical trials is available from the NCI website.
                
                
                    Patients may want to think about taking part in a clinical trial.
                    For some patients, taking part in a clinical trial may be the best treatment choice. Clinical trials are part of the cancer research process. Clinical trials are done to find out if new cancer treatments are safe and effective or better than the standard treatment.   Many of today's standard treatments for cancer are based on earlier clinical trials. Patients who take part in a clinical trial may receive the standard treatment or be among the first to receive a new treatment.   Patients who take part in clinical trials also help improve the way cancer will be treated in the future. Even when clinical trials do not lead to effective new treatments, they often answer important questions and help move research forward.
                
                
                    Patients can enter clinical trials before, during, or after starting their cancer treatment.
                    Some clinical trials only include patients who have not yet received treatment. Other trials test treatments for patients whose cancer has not gotten better. There are also clinical trials that test new ways to stop cancer from recurring (coming back) or reduce the side effects of cancer treatment.   Clinical trials are taking place in many parts of the country. See the Treatment Options section that follows for links to current treatment clinical trials. These have been retrieved from NCI's listing of clinical trials.
user: What is (are) Adult Primary Liver Cancer ?

assistant: Key Points
                    - Adult primary liver cancer is a disease in which malignant (cancer) cells form in the tissues of the liver.    - There are two types of adult primary liver cancer.    - Having hepatitis or cirrhosis can affect the risk of adult primary liver cancer.     - Signs and symptoms of adult primary liver cancer include a lump or pain on the right side.     - Tests that examine the liver and the blood are used to detect (find) and diagnose adult primary liver cancer.    - Certain factors affect prognosis (chance of recovery) and treatment options.
                
                
                    Adult primary liver cancer is a disease in which malignant (cancer) cells form in the tissues of the liver.
                    The liver is one of the largest organs in the body. It has four lobes and fills the upper right side of the abdomen inside the rib cage. Three of the many important functions of the liver are:         - To filter harmful substances from the blood so they can be passed from the body in stools and urine.    - To make bile to help digest fat that comes from food.     - To store glycogen (sugar), which the body uses for energy.
                
                
                    There are two types of adult primary liver cancer.
                    The two types of adult primary liver cancer are:         -  Hepatocellular carcinoma.    -  Cholangiocarcinoma (bile duct cancer). (See the PDQ summary on Bile Duct Cancer Treatment for more information.)        The most common type of adult primary liver cancer is hepatocellular carcinoma. This type of liver cancer is the third leading cause of cancer-related deaths worldwide.   This summary is about the treatment of primary liver cancer (cancer that begins in the liver). Treatment of cancer that begins in other parts of the body and spreads to the liver is not covered in this summary.    Primary liver cancer can occur in both adults and children. However, treatment for children is different than treatment for adults. (See the PDQ summary on Childhood Liver Cancer Treatment for more information.)
user: Who is at risk for Adult Primary Liver Cancer? ?

assistant: Having hepatitis or cirrhosis can affect the risk of adult primary liver cancer. Anything that increases your chance of getting a disease is called a risk factor. Having a risk factor does not mean that you will get cancer; not having risk factors doesnt mean that you will not get cancer. Talk with your doctor if you think you may be at risk.    The following are risk factors for adult primary liver cancer:         - Having hepatitis B or hepatitis C. Having both hepatitis B and hepatitis C increases the risk even more.    -  Having cirrhosis, which can be caused by:               -  hepatitis (especially hepatitis C); or       - drinking large amounts of alcohol for many years or being an alcoholic.              - Having metabolic syndrome, a set of conditions that occur together, including extra fat around the abdomen, high blood sugar, high blood pressure, high levels of triglycerides and low levels of high-density lipoproteins in the blood.     - Having liver injury that is long-lasting, especially if it leads to cirrhosis.    - Having hemochromatosis, a condition in which the body takes up and stores more iron than it needs. The extra iron is stored in the liver, heart, and pancreas     - Eating foods tainted with aflatoxin (poison from a fungus that can grow on foods, such as grains and nuts, that have not been stored properly).
user: What are the symptoms of Adult Primary Liver Cancer ?

assistant: Signs and symptoms of adult primary liver cancer include a lump or pain on the right side. These and other signs and symptoms may be caused by adult primary liver cancer or by other conditions. Check with your doctor if you have any of the following:         - A hard lump on the right side just below the rib cage.    -  Discomfort in the upper abdomen on the right side.    - A swollen abdomen.    -  Pain near the right shoulder blade or in the back.    -  Jaundice (yellowing of the skin and whites of the eyes).    - Easy bruising or bleeding.    - Unusual tiredness or weakness.    -  Nausea and vomiting.    - Loss of appetite or feelings of fullness after eating a small meal.    - Weight loss for no known reason.    - Pale, chalky bowel movements and dark urine.    -  Fever.
user: What is the outlook for Adult Primary Liver Cancer ?

assistant: Certain factors affect prognosis (chance of recovery) and treatment options. The prognosis (chance of recovery) and treatment options depend on the following:         - The stage of the cancer (the size of the tumor, whether it affects part or all of the liver, or has spread to other places in the body).    - How well the liver is working.    - The patients general health, including whether there is cirrhosis of the liver.
user: what research (or clinical trials) is being done for Adult Primary Liver Cancer ?

assistant: New types of treatment are being tested in clinical trials.
                    Information about clinical trials is available from the NCI website.
                
                
                    Patients may want to think about taking part in a clinical trial.
                    For some patients, taking part in a clinical trial may be the best treatment choice. Clinical trials are part of the cancer research process. Clinical trials are done to find out if new cancer treatments are safe and effective or better than the standard treatment.   Many of today's standard treatments for cancer are based on earlier clinical trials. Patients who take part in a clinical trial may receive the standard treatment or be among the first to receive a new treatment.   Patients who take part in clinical trials also help improve the way cancer will be treated in the future. Even when clinical trials do not lead to effective new treatments, they often answer important questions and help move research forward.
                
                
                    Patients can enter clinical trials before, during, or after starting their cancer treatment.
                    Some clinical trials only include patients who have not yet received treatment. Other trials test treatments for patients whose cancer has not gotten better. There are also clinical trials that test new ways to stop cancer from recurring (coming back) or reduce the side effects of cancer treatment.   Clinical trials are taking place in many parts of the country. See the Treatment Options section that follows for links to current treatment clinical trials. These have been retrieved from NCI's listing of clinical trials.
user: What is (are) Prostate Cancer ?

assistant: Key Points
                    - Prostate cancer is a disease in which malignant (cancer) cells form in the tissues of the prostate.    - Prostate cancer is the most common nonskin cancer among men in the United States.    - Different factors increase or decrease the risk of developing prostate cancer.
                
                
                    Prostate cancer is a disease in which malignant (cancer) cells form in the tissues of the prostate.
                    The prostate is a gland in the male reproductive system located just below the bladder (the organ that collects and empties urine) and in front of the rectum (the lower part of the intestine). It is about the size of a walnut and surrounds part of the urethra (the tube that empties urine from the bladder). The prostate gland produces fluid that makes up part of semen.      As men age, the prostate may get bigger. A bigger prostate may block the flow of urine from the bladder and cause problems with sexual function. This condition is called benign prostatic hyperplasia (BPH), and although it is not cancer, surgery may be needed to correct it. The symptoms of benign prostatic hyperplasia or of other problems in the prostate may be similar to symptoms of prostate cancer.      See the following PDQ summaries for more information about prostate cancer:         -   Prostate Cancer Prevention     -  Prostate Cancer Treatment
user: Who is at risk for Prostate Cancer? ?

assistant: Prostate cancer is the most common nonskin cancer among men in the United States. Prostate cancer is found mainly in older men. Although the number of men with prostate cancer is large, most men diagnosed with this disease do not die from it. Prostate cancer causes more deaths in men than any other cancer except lung cancer and colorectal cancer. Prostate cancer occurs more often in African-American men than in white men. African-American men with prostate cancer are more likely to die from the disease than white men with prostate cancer.
user: Who is at risk for Prostate Cancer? ?

assistant: Different factors increase or decrease the risk of developing prostate cancer. Anything that increases a person's chance of developing a disease is called a risk factor. Anything that decreases your chance of getting a disease is called a protective factor.   For information about risk factors and protective factors for prostate cancer, see the PDQ summary on Prostate Cancer Prevention.
user: Who is at risk for Childhood Central Nervous System Embryonal Tumors? ?

assistant: Certain genetic conditions increase the risk of childhood CNS embryonal tumors. Anything that increases the risk of getting a disease is called a risk factor. Having a risk factor does not mean that you will get cancer; not having risk factors doesnt mean that you will not get cancer. Talk with your childs doctor if you think your child may be at risk.    Risk factors for CNS embryonal tumors include having the following inherited diseases:         -  Turcot syndrome.    -  Rubinstein-Taybi syndrome.    -  Nevoid basal cell carcinoma (Gorlin) syndrome.    -  Li-Fraumeni syndrome.    -  Fanconi anemia.        In most cases, the cause of CNS embryonal tumors is not known.
user: What are the symptoms of Childhood Central Nervous System Embryonal Tumors ?

assistant: Signs and symptoms of childhood CNS embryonal tumors or pineoblastomas depend on the child's age and where the tumor is. These and other signs and symptoms may be caused by childhood CNS embryonal tumors, pineoblastomas, or other conditions. Check with your child's doctor if your child has any of the following:         - Loss of balance, trouble walking, worsening handwriting, or slow speech.    - Lack of coordination.    - Headache, especially in the morning, or headache that goes away after vomiting.    - Double vision or other eye problems.    -  Nausea and vomiting.    - General weakness or weakness on one side of the face.    - Unusual sleepiness or change in energy level.    -  Seizures.        Infants and young children with these tumors may be irritable or grow slowly. Also they may not eat well or meet developmental milestones such as sitting, walking, and talking in sentences.
user: How to diagnose Childhood Central Nervous System Embryonal Tumors ?

assistant: Tests that examine the brain and spinal cord are used to detect (find) childhood CNS embryonal tumors or pineoblastomas. The following tests and procedures may be used:         -   Physical exam and history : An exam of the body to check general signs of health, including checking for signs of disease, such as lumps or anything else that seems unusual. A history of the patients health habits and past illnesses and treatments will also be taken.     -   Neurological exam : A series of questions and tests to check the brain, spinal cord, and nerve function. The exam checks a patient's mental status, coordination, and ability to walk normally, and how well the muscles, senses, and reflexes work. This may also be called a neuro exam or a neurologic exam.     -  MRI (magnetic resonance imaging) of the brain and spinal cord with gadolinium : A procedure that uses a magnet, radio waves, and a computer to make a series of detailed pictures of areas inside the brain and spinal cord. A substance called gadolinium is injected into a vein. The gadolinium collects around the cancer cells so they show up brighter in the picture. This procedure is also called nuclear magnetic resonance imaging (NMRI). Sometimes magnetic resonance spectroscopy (MRS) is done during the MRI scan to look at the chemicals in brain tissue.     -   Lumbar puncture : A procedure used to collect cerebrospinal fluid (CSF) from the spinal column. This is done by placing a needle between two bones in the spine and into the CSF around the spinal cord and removing a sample of the fluid. The sample of CSF is checked under a microscope for signs of tumor cells. The sample may also be checked for the amounts of protein and glucose. A higher than normal amount of protein or lower than normal amount of glucose may be a sign of a tumor. This procedure is also called an LP or spinal tap.
                    A biopsy may be done to be sure of the diagnosis of CNS embryonal tumor or pineoblastoma. If doctors think your child may have a CNS embryonal tumor or pineoblastoma, a biopsy may be done. For brain tumors, the biopsy is done by removing part of the skull and using a needle to remove a sample of tissue. Sometimes, a computer-guided needle is used to remove the tissue sample. A pathologist views the tissue under a microscope to look for cancer cells. If cancer cells are found, the doctor may remove as much tumor as safely possible during the same surgery. The piece of skull is usually put back in place after the procedure.    The following test may be done on the sample of tissue that is removed:         -   Immunohistochemistry : A test that uses antibodies to check for certain antigens in a sample of tissue. The antibody is usually linked to a radioactive substance or a dye that causes the tissue to light up under a microscope. This type of test may be used to tell the difference between different types of brain tumors.
user: What is the outlook for Childhood Central Nervous System Embryonal Tumors ?

assistant: Certain factors affect prognosis (chance of recovery) and treatment options. The prognosis (chance of recovery) and treatment options depend on:          - The type of tumor and where it is in the brain.     - Whether the cancer has spread within the brain and spinal cord when the tumor is found.    - The age of the child when the tumor is found.     - How much of the tumor remains after surgery.    - Whether there are certain changes in the chromosomes, genes, or brain cells.    - Whether the tumor has just been diagnosed or has recurred (come back).